Roche (OTCQX:RHHBY) (OTCQX:RHHBF) will finalize the acquisition of Poseida Therapeutics (NASDAQ:PSTX), a biopharmaceutical ...

Roche on Wednesday said it planned to complete its purchase of U.S. biopharmaceutical company Poseida Therapeutics , a ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche’s wholly owned subsidiary Blue Giant Acquisition Corp. has ...

Roche's strategic changes in drug development and M&A activity may drive future growth, despite recent setbacks in clinical ...

(Alliance News) - Roche Holding AG on Wednesday said that it has completed the tender offer for all outstanding shares of Poseida Therapeutics Inc, a clinical-stage biopharmaceutical company, through ...

Recent health news includes Donald Trump's consideration of an executive order on gas stoves, Roche's acquisition of Poseida, ...

Poseida Therapeutics Inc (PSTX) stock saw a decline, ending the day at $9.4 which represents a decrease of $-0.20 or -2.08% from the prior close of $9.6. The stock opened at $9.54 and touched a low of ...

Piper Sandler has recently reduced Poseida Therapeutics Inc (PSTX) stock to Neutral rating, as announced on December 2, 2024, according to Finviz. Earlier, on January 4, 2023, H.C. Wainwright had ...

Shares of Poseida Therapeutics, Inc. (NASDAQ:PSTX – Get Free Report) hit a new 52-week high on Tuesday . The stock traded as ...

Poseida Therapeutics, Inc. (NASDAQ:PSTX), a biotechnology company ... with Astellas providing $50 million and Roche (LON:0QQ6) contributing $15 million. These infusions brought Poseida's pro forma ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's wholly owned subsidiary Blue Giant Acquisition Corp. has accepted for payment all shares validly tendered and not ...